Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Engineering a Photoactive Live Bacterial Hybrid: MXene/[email protected] for Oxygenation-Boosted Cancer Immunotherapy.

Created on 22 Sep 2026

Authors

Ammavasi Chandran Ambigaibalan, Sivaraj Mehnath, Kannaiyakumar Dharshini, Arivalagan Ponbharathi, Chithaiyan Kamaladevi Sowndharya, Murugaraj Jeyaraj

Published in

ACS applied bio materials. Sep 21, 2026. Epub Sep 21, 2026.

Abstract

Hypoxic conditions in the tumor microenvironment, which escape immune surveillance, are a major hindrance to controlling the antitumor effect of nanomaterials. In this work, MXene/MoS2 @M.bvs photoactive live bacteria were developed. NIR irradiation elevates the oxygen level, induces the photothermal effect, interferes with the Ado A2A receptor (Adenosine A2AR) metabolic pathway, and triggers cancer immunotherapy. An acid-etched MXene sheet was fabricated from the MAX phase; exfoliated MoS2 was composited with a thin MXene sheet to form self-assembled MXene/MoS2. Nanocomposites were conjugated to Mycobacterium bovis (M.bvs) through a carbodiimide reaction, and they formed a stable rod shape, as confirmed through HRTEM analysis. The in vitro catalytic effect of MXene/[email protected] toward H2O2 was evaluated, and a reduction of the Ado level was observed by downregulation of A2AR expression. Nanocomposites not only improved the photothermal effect but also were directly involved in the immune stimulation. The level of cytokine production and cytotoxic T-cell activation was higher for MXene/[email protected] compared to the MXene/MoS2. In vivo studies showed that MXene/[email protected] + NIR exhibited higher antitumor activity, longer survival time, biosafety, and inhibition of tumor growth. It also promotes DC maturation, increases TNF-α and IL-6, and induces a potent antitumor immune response. Overall, the photoactive live bacterial nanocomposites effectively enhance the synergistic effect of photothermal cancer immunotherapy.

PMID:
42766367
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement